Respiratory Tract Infections (RTI) Terminated Phase 3 Trials for Siltuximab (DB09036)

Also known as: Infection, Respiratory Tract / Infections, Respiratory Tract / Respiratory tract infections NEC / Respiratory Tract Infection / Recurrent Upper and Lower Respiratory Tract Infections (RTIs) / Respiratory Tract Infections / Infection respiratory / Respiratory infection / Respiratory tract infection (disorder) / Respiratory tract infection NOS / RTI / Unspecified respiratory tract infection

IndicationStatusPhase
DBCOND0070409 (Respiratory Tract Infections (RTI))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04616586
SILtuximab in Viral ARds (SILVAR) StudyTreatment